Bulk Inquiry
KD025
- SLx-2119 - Belumosudil
- Soluble in 0.1N HCl(aq) and DMSO
- MF: C26H24N6O2
- MW: 452.51
Description
KD025 is a selective, ATP-competitive inhibitor of human ROCK2 (IC50 value of 105 nM) with minimal effects on human ROCK1 (IC50 value of 24 µM).
More Information
| Parent CAS No. | 911417-87-3 |
|---|---|
| Chemical Name | 2-(3-(4-(1H-Indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide |
| SMILES | C1C=C2C(NC3C=CC4NN=CC=4C=3)=NC(C3C=C(OCC(=O)NC(C)C)C=CC=3)=NC2=CC=1 |
| MFCD | N.A. |
| InChi | InChI=1S/C26H24N6O2/c1-16(2)28-24(33)15-34-20-7-5-6-17(13-20)25-30-23-9-4-3-8-21(23)26(31-25)29-19-10-11-22-18(12-19)14-27-32-22/h3-14,16H,15H2,1-2H3,(H,27,32)(H,28,33)(H,29,30,31) |
| InChiKey | GKHIVNAUVKXIIY-UHFFFAOYSA-N |
| CID | 11950170 |
| Short Description | ROCK2 inhibitor |
References
- M Boerma et al. Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. Blood Coagul Fibrinolysis. 2008 Oct;19(7):709-18.
- DTV Diep et al. Anti-adipogenic effects of KD025 (SLx-2119), a ROCK2-specific inhibitor, in 3T3-L1 cells. Sci Rep. 2018 Feb 6;8(1):2477.
- JH Lee et al. Selective ROCK2 Inhibition In Focal Cerebral Ischemia. Ann Clin Transl Neurol. 2014 Jan 1;1(1):2-14.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1167 | GSK 269962A |
From $77.00 |
| 1535 | Thiazovivin |
From $99.00 |
| 1683 | Y 27632 dihydrochloride |
From $71.50 |
| 2166 | AT 13148 dihydrochloride |
From $77.00 |
| 2187 | AS 1892802 |
From $104.50 |
| 2229 | RKI 1447 |
From $115.50 |
| 2753 | CCG 232601 |
From $176.00 |
| 3092 | CCG-203971 |
From $66.00 |
| 3848 | Fasudil hydrochloride |
From $55.00 |
| 5009 | Stem Cell 4i inhibitor Set |
From $187.00 |
| 5010 | Naive Stem Cell NHSM inhibitor Set |
From $253.00 |
| 5011 | Naive Stem Cell 5i inhibitor Set |
From $220.00 |
